Protalix BioTherapeutics (PLX) Deferred Taxes (2023 - 2026)
Protalix BioTherapeutics' (PLX) quarterly Deferred Taxes came in at $71000.0 in Q1 2026, up 162.83% year-on-year from $27013.5 in Q1 2025, and down 56.44% quarter-over-quarter from $163000.0 in Q4 2025.
Protalix BioTherapeutics (PLX) Deferred Taxes (2023 - 2026) Analysis & Trends
Protalix BioTherapeutics' Deferred Taxes history runs 4 years deep, the most recent figure standing at $71000.0 for Q1 2026.
- On a quarterly basis, Deferred Taxes rose 162.83% year-over-year to $71000.0 in Q1 2026; TTM through Mar 2026 was $524000.0, a 100.77% increase from a year earlier, with the FY2025 full-year figure at $340000.0, up 44.07% from the prior year.
- Deferred Taxes eased to $71000.0 in Q1 2026 per PLX's latest filing, from $163000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $443000.0 in Q3 2024 and bottomed at -$3.1 million in Q2 2023.
- The 4-year median for Deferred Taxes is $48500.0 (2023), against an average of -$244500.0.
- Across the five-year window, Deferred Taxes jumped 1065.79% in 2024 and slumped 86.68% in 2025, its largest moves.
- Year by year, Deferred Taxes stood at $38000.0 in 2023, then soared by 1065.79% to $443000.0 in 2024, then sank by 63.21% to $163000.0 in 2025, then slumped by 56.44% to $71000.0 in 2026.
- Per Business Quant, the three latest PLX Deferred Taxes figures stand at $71000.0 (Q1 2026), $163000.0 (Q4 2025), and $59000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn | 71,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | 163,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 231,000.00 |
| Mar 31, 2025 | -113,000.00 |
| Sep 30, 2024 | 443,000.00 |
| Jun 30, 2024 | -69,000.00 |
| Mar 31, 2024 | -138,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Jun 30, 2023 | -3.13 Mn |